Nuphar lutea
Connections displayed (default: 10).
Loading graph...
| Scientific Name | Nuphar lutea |
|---|---|
| Database Name | cmaup_plants |
| Synonyms | Nuphar Lutea |
| Ipni Id | 30385379-2 |
| Plant Name | Nuphar Lutea |
| Genus Tax Id | 4415 |
| Disease Name | Myocardial infarction, Type 2 diabetes mellitus, Migraine, Breast cancer, Lung cancer, Low bone mass disorder, Malignant haematopoietic neoplasm, Atopic eczema, Genetic prion disease, Common warts, Diffuse large B-cell lymphoma, Pain, unspecified, Asthma, Functional bladder disorder, Chemoprotection, Psoriasis, Alzheimer disease, Retinopathy, Solid tumour/cancer, HIV-infected patients with tuberculosis, Pancreatic cancer, Obesity, Acute myeloid leukaemia, Kaposi sarcoma, Seborrhoeic dermatitis, Duodenal ulcer, Rheumatoid arthritis, Visual system disease, Irritable bowel syndrome, Bacterial infection, Inborn lipid metabolism error, Osteoarthritis, Colorectal cancer, Brain cancer, Heart failure, Glaucoma, Amyloidosis, Otitis externa, Cardiovascular disease, Anogenital warts, Mature B-cell lymphoma, Ovarian cancer, Melanoma, Desmoid tumour, Thrombosis, Muscular dystrophy, Chronic kidney disease, Multiple sclerosis, Chronic pain, Acute diabete complication, Myeloproliferative neoplasm, Urinary tract infection, Myelodysplastic syndrome, Dyslipidemia, Thrombocytosis, Crohn disease, Multiple myeloma, Prostate cancer, Thrombocytopenia, Hypo-thyroidism, Ovarian dysfunction, Schizophrenia, Cerebral ischaemic stroke, Liver cancer, Motor neuron disease, Ischaemic/haemorrhagic stroke, Cataract, Mature B-cell leukaemia, Hyper-lipoproteinaemia, Stomach cancer, Lower limb mononeuropathy, Follicular lymphoma, Insomnia, Essential hypertension, Idiopathic interstitial pneumonitis, Thyroid cancer, Acute/subacute hepatic failure, Colon cancer, Mature T-cell lymphoma, Coronary thrombosis, Parkinsonism, Bleeding disorder, Bladder cancer, Choreiform disorder, Metabolic disorder, Knee osteoarthritis, Respiratory system disease, Fungal infection, Chronic myelomonocytic leukaemia, Nicotine use disorder, Gonococcal infection, Attention deficit hyperactivity disorder, Diabetes mellitus, type unspecified, General pain disorder, Dystrophic epidermolysis bullosa, Anorexia nervosa, Neuropathy, Coagulation defect, Autonomic nervous system disorder, Angina pectoris, Lupus erythematosus, Skin and skin-structure infection, Cannabis use disorder, Parasitic infection, Female pelvic pain, Renal cell carcinoma, Diagnostic imaging, Indeterminate colitis, Otitis media, Pituitary gland disorder, Syphilis, Chronic arterial occlusive disease, BCR-ABL1-negative chronic myeloid leukaemia, Nausea/vomiting, Nutritional deficiency, Head and neck cancer, Acute ischaemic heart disease, unspecified, Myasthenia gravis, Unspecified malignant neoplasms of unspecified sites, Allergic/hypersensitivity disorder, Retinoblastoma, Medulloblastoma, NOS, Primary haemophagocytic lymphohistiocytosis, Small cell carcinoma of bronchus or lung, Non-small cell lung cancer, coronary artery disease, Oligoastrocytoma, Ischaemic heart diseases, unspecified, Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified, Hodgkin lymphoma, Precursor cell lymphoblastic leukaemia, NOS, Malignant lymphoma, not elsewhere classified, Central nervous system disease, Epilepsy/seizure, Spina bifida, unspecified, Recurrent pregnancy loss, Oligodendroglioma, anaplastic, Neuroblastoma, NOS, Iron deficiency anaemia, Neoplasms, Leukaemia, Adenocarcinoma of prostate, Sickle-cell disorder, Acute basophilic leukaemia, Systemic lupus erythematosus, Type1diabetesmellitus, Fragile X chromosome, Mixed hyperlipidaemia, Pulmonary hypertension, Anemia, Burkitt lymphoma, NOS, Teratoma, NOS, Acute myelomonocytic leukaemia, Malignant neoplasms of nasopharynx, Septic shock, Germinoma, Polycystic ovary syndrome, Classical Hodgkin lymphoma, Primary neoplasms of brain, Precursor B-lymphoblastic neoplasm, Malignant neoplasms of kidney, except renal pelvis, Acute monocytic leukaemia, Pleural mesothelioma, Hyperlipidemia, Hypercholesterolaemia, Castlemans disease, Retinal vascular occlusion, Pleomorphic sarcoma, Sezary syndrome, Esophageal cancer, Coronary atherosclerosis, Neoplasms of unknown behaviour of urinary organs, Mantle cell lymphoma, Diseases of the blood or blood-forming organs, unspecified, Lichen planus, Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of stomach, Chronic lymphocytic leukaemia or small lymphocytic lymphoma, Osteoporosis, Malignant lymphoma, NOS, Ewing sarcoma, Soft tissue disorder, Autism spectrum disorder, Peripheral T-cell lymphoma, not otherwise specified, Seminoma, NOS, Neoplasms of unknown behaviour of breast, Refractory anaemia with excess of blasts, Malignant neoplasms of thymus, Neuroendocrine carcinoma, Structural developmental anomaly of heart or great vessels, unspecified, Malignant neoplasms of colon, Acute erythroid leukaemia, COVID-19, Extranodal NK/T-cell lymphoma, nasal type, Anaplastic large cell lymphoma, NOS, Cleft palate, Germ cell tumour of testis, Testicular cancer, Other specified infectious meningitis not elsewhere classified, Chronic myeloid leukaemia, NOS, Chronic kidney disease, stage unspecified, Galactose-1-phosphate uridyltransferase deficiency, Cervical cancer, Malignant neoplasm of pancreas, unspecified, Pulmonary alveolar proteinosis, Ductal carcinoma in situ of breast, Malaria, Acute megakaryoblastic leukaemia, Waldenstrom macroglobulinemia, Male infertility, Osteosarcoma, CNS embryonal tumour, NOS, Sepsis, Huntington disease, Harmful effects of drugs, medicaments or biological substances, not elsewhere classified, Rhabdomyosarcoma, NOS, Anterior uveitis, Cardiac arrest, Non-alcoholic fatty liver disease, Lymphoid leukaemia, NOS, Breast in situ carcinoma, Neuroendocrine neoplasms of pancreas, Glioblastoma, primary, NOS, Mild hyperemesis gravidarum, Dental caries, Single episode depressive disorder, severe, without psychotic symptoms, Cleft lip, Graft-versus-host disease, Cutaneous T-cell lymphoma, NOS, Malignant neoplasms of retroperitoneum, Human immunodeficiency virus type 1, Bipolar disorder, Idiopathic pulmonary fibrosis, Asymptomatic stenosis of intracranial or extracranial artery, Gliosarcoma, Flushing, Optic nerve disorder, Schizophrenia or other primary psychotic disorders, unspecified, Adenocarcinoma, Becker muscular dystrophy, Mature B-cell neoplasms, unspecified, Respiratory failure, Other specified gliomas of brain, Macular degeneration, Myeloid sarcoma, Melasma, Embryonal rhabdomyosarcoma, NOS, Periodontal disease, Hepatic fibrosis/cirrhosis, Congestive heart failure, Oral mucositis, Fallopian tube cancer, Malignant neoplasms of stomach, Ganglioneuroblastoma, Cystic fibrosis, Malignant neoplasms of oropharynx, Pre-eclampsia, Atherosclerotic chronic arterial occlusive disease, unspecified, Hepatocellular carcinoma, NOS, Ischemic heart disease, Endometriosis, Uterine fibroid, Haemorrhage, not elsewhere classified, Hepatoblastoma, Malignant trophoblastic neoplasms of placenta, T lymphoblastic leukaemia/lymphoma, Pilocytic astrocytoma, Other specified malignant neoplasms of the ovary, Squamous cell carcinoma, Other specified malignant neoplasms of kidney, except renal pelvis, Metastatic digestive system neoplasm, Neuromyelitis optica, Intracranial injury, unspecified, Glioma, malignant, Adult T-cell lymphoma or leukaemia, human T-cell lymphotropic virus type 1-associated, Movement disorder, Adult T-cell leukaemia/lymphoma (HTLV-1 positive), Rectum cancer, Ependymoma, NOS, Tuberculosis of the respiratory system, Other specified disorders of carbohydrate absorption or transport, Malignant neoplasm metastasis in mediastinum, Embryonal carcinoma, NOS, Mental/behavioural/neurodevelopmental disorder, Chronic arterial occlusive disease, unspecified, Myeloproliferative neoplasm, NOS, Malignant neoplasms of bladder, unspecified, Cerebrovascular diseases, unspecified, Alcoholic hepatitis, Choroid plexus tumours, Nephroblastoma, NOS, Complete trisomy 21, Tumours of neuroepithelial tissue of brain, Beta thalassaemia, Unspecified viral infection of unspecified site, Adrenal cortical carcinoma, Diabetic lactic acidosis, Refractory anaemia, Depressive disorders, unspecified, Aortic valve stenosis, Infantile spasms, Myeloproliferative and myelodysplastic disease, unclassifiable, Relapsing-remitting multiple sclerosis, Neutropenia, Duchenne muscular dystrophy, Thymoma, Xerostomia, Mycosis fungoides, Skin cancer, Noninfectious erosive or ulcerative disorders of oral mucosa, Oligodendroglioma, NOS, Congenital human immunodeficiency virus infection, Small cell carcinoma, NOS, Columnar metaplastic epithelium of the oesophagus, unspecified, Ependymoma, anaplastic, Paraneoplastic or autoimmune disorders of the central nervous system, brain or spinal cord, Obsessive-compulsive disorder, Multiple system atrophy, Other specified syndromes with multiple structural anomalies, not of environmental origin, Astrocytoma, anaplastic, Post-traumatic stress disorder, Argininosuccinic aciduria, Inappropriate saccades, Alveolar rhabdomyosarcoma, Chronic inflammatory demyelinating polyneuropathy, Disorders of methionine cycle or sulphur amino acid metabolism, Prostate hyperplasia, Carcinosarcoma of uterus, Coeliac disease, Serous cystadenoma,borderline malignancy of ovary, Pheochromocytoma, Myelodysplastic syndromes, unspecified, Inflammatory bowel diseases, unspecified, Osteoarthritis, unspecified, Dengue fever, unspecified, Malignant neoplasms of biliary tract, distal bile duct, Leishmaniasis, Adenocarcinoma of stomach, Atrial fibrillation, Malignant neoplasm metastasis in lymph nodes of head, face or neck, Diffuse large B-cell lymphomas, Keratoconus, Squamous cell carcinoma of bronchus or lung, West Nile virus infection, Adenocarcinoma of pancreas, Mesothelioma of pleura, Tetralogy of Fallot, Other specified malignant neoplasms ofcolon, Melanoma of skin, Hepatocellular carcinoma of liver, Other specified malignant neoplasms of bronchus or lung, Superficial ovarian endometriosis, Malignant neoplasms of oesophagus, Urothelial carcinoma of bladder, Cytomegaloviral disease, Chronic rhinosinusitis, Malignant neoplasms of thyroid gland, unspecified, Adenocarcinoma of bronchus or lung, Malignant neoplasms of corpus uteri, unspecified, Chikungunya virus disease, Invasive carcinoma of breast, Malaria, unspecified, Human immunodeficiency virus disease without mention of tuberculosis or malaria, Glioblastoma of brain, Renal cell carcinoma, chromophobe type, Carpal tunnel syndrome, Ebola virus disease, Malignant neoplasms of adrenal gland, Lyme borreliosis, Gliomas of brain |
| Species Name | Nuphar lutea |
| Genus Name | Nuphar |
| Species Tax Id | 77113 |
| Disease Id | BA41-BA43, 5A11, 8A80, 2C60-2C6Y, 2C25, FB83, 2B33, EA80, 8.00E+02, 1.00E+80, 2A81, MG3Z, CA23, GC50, N.A., EA90, 8A20, 9B71, 2A00-2F9Z, 1B10-1B14, 2C10, 5B80-5B81, 2A60, 2B57, EA81, DA63, FA20, 9E1Z, DD91, 1A00-1C4Z, 5C52, FA00-FA05, 2B91, 2A00, BD10-BD1Z, 9C61, 5D00, AA00-AA13, BA00-BE2Z, 1A95, 2A85, 2C73, 2C30, 2F7C, DB61-GB90, 8C70, GB61, 8A40, MG30, 5A2Y, 2A20, GC08, 2A37, 5C80-5C81, 3B63, DD70, 2A83, 2C82, 3B64, 5A00, 5A80, 6A20, 8B11, 2C12, 8B60, 8B20, 9B10, 2A82, 5C80, 2B72, 8C11, 2A80, 7A00-7A0Z, BA00, CB03, 2D10, DB91, 2B90, 2A90, BA43, 8A00, GA20-GA21, 2C94, 8A01, 5C50-5D2Z, FA01, CB40-CB7Z, 1F29-1F2F, 2A40, 6C4A, 1A70-1A7Z, 6A05, 5A14, 8.00E+43, EC32, 6B80, 8C0Z, 3B10, 8D87, BA40, 4A40, 1F28-1G0Z, 6C41, 1D0Y-1G2Z, GA34, 2C90, DD72, AA80-AB0Z, 5A60-5A61, 1A61-1A6Z, BD4Z, 2A41, MD90, 5B50-5B71, 2D42, BA4Z, 8C6Y, 2D4Z, 4A80-4A8Z, 2D02.2, XH8P29, 4A01.23, 2C25.1, BA8Y-BA8Z, XH6F49, BA6Z, 1C62.Z, 2B30, XH5J37, 2B33.5, 8A04-8D87, 8A61-8A6Z, LA02.Z, GA33, XH8844, XH85Z0, 3A00, 2, 2A60-2B33, 2C82.0, 3A51, 2A60.37, 4A40.0, 5A10, LD55, 5C80.2, BB01, 3A00-3A9Z, XH4KA9, XH83G5, XH78Y4, 2B6B, XS26, XH1E13, 5A80.1, 2B30.1, 2A70, XH9NE2, 2C26, 5C80.0, 4B2Y, 9B74, 2B54, XH8HN3, 2B70, BA80, 2F98, 2A85.5, 3C0Z, EA91, 2A85.1, 2A82.0, FB83.1, XH5FJ5, 2B52, FB56, 6A02, 2A90.C, XH9FM4, 2F95, 2A35, 2C27, 2C34, LA8Z, 2A60.35, 1D6Y, 2A90.6, XH1LC0, LA42, 2C80.2, 2C80, 1D01.Y, XH4XG8, GB61.Z, 5C51.40, 2C77, 2C10.Z, CB04.31, 2E65.2, 1F40-1F45, 2A60.36, XH8GW4, GB04, 2B51, XH8SH6, 1G40-1G41, 8A01.10, NE60, XH0GA1, 9A96, MC82, DB92, XH7Q12, 2.00E+65, 2C10.1, XH0MB1, JA60.0, DA08.0, 6A70.3, LA40, 4B24, XH1951, 2C50, XN8LD, 6A60, CB03.4, BD55, XH9RC8, ME64.4, 9C40, 6A2Z, 2D40, 8C70.0, 2A8Z, CB41, 2A00.0Y, 9B75, 2A60.39, ED60.1, XH83G1, DA0C, DB93, BD10, DA01, 2C74, XH77W7, CA25, 2B6A, JA24, BD40.Z, XH4W48, BA40-BA6Z, GA10, 2.00E+66, MG27, 2C12.01, 2C75.0, XH50W7, XH12D2, 2C73.Y, 2B60-2D01, 2C90.Y, 2D8Y, 8A43, NA07.Z, XH4RQ3, 2A90.5, 8A07-8A0Z, XH6TE2, 2B92, XH1511, 1B10, 5C61.Y, 2D71, XH8MB9, 6E20-6E8Z, XH5HH7, 2C94.Z, 8B2Z, DB94.1, 2A00.22, XH5QN3, LD40.0, 2A00.2, 3A50.2, 1D9Z, XH4KH2, 5A22.1, 2A30, 6A7Z, BB70, 8A62.0, 2A44, 8A40.0, 4B00, 8C70.1, DA02.1, 2B01, 2C30-2C37, DA01.1, XH7W59, KA62.6, XH0YB0, DA23.Z, XH6922, 8E4A.0, 6B20, 8D87.0, LD2F.1Y, XH96C7, 6B40, 5C50.A0, 9C85.02, XH7099, 8C01.3, 5C50.B, GA90, 2C76.43, DA95, 2C73.4, XH3854, 2A3Z, DD7Z, FA0Z, 1D2Z, 2C15, 1F54, 2B72.0, BC81.3, 2D60.0, 9A78.50, 2C25.2, 1D46, 2C10.0, 2C26.0, LA88.2, 2B90.Y, 2C12.02, 2C25.Y, GA10.B4, 2C94.2, 1D82, CA0A, 2D10.Z, 2C25.0, 2C76.Z, 1D40, 2C61, 1F4Z, 1C62, 2A00.00, XH6153, 8C10.0, 1D60.01, 2D11, 1C1G, 2A00.0 |
| Family Name | Nymphaeaceae |
| Family Tax Id | 4410 |
- 1. (+)-Stephacidin A (PubChem CID: 16127922)
- 2. (+-)-Pantothenic Acid (PubChem CID: 988)
- 3. (1r)-3,5,5-Trimethyl-4-[(3e,5e,7e,9e,11e,13e,15e,17e)-3,7,12,16-Tetramethyl-18-[(1r)-2,6,6-Trimethylcyclohex-2-En-1-Yl]octadeca-3,5,7,9,11,13,15,17-Octaen-1-Ynyl]cyclohex-3-En-1-Ol (PubChem CID: 101289802)
- 4. (1r,2r)-2-[(1e,3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyloctadeca-1,3,5,7,9,11,13,15-Octaen-17-Ynyl]-1,3,3-Trimethylcyclohexane-1,2-Diol (PubChem CID: 163014206)
- 5. (1r,2r,20r,42r,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3r,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162996097)
- 6. (1r,2r,20r,42r,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3s,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163193936)
- 7. (1r,2r,20r,42s,46r)-15-[(1r,2s,20s,42s,46s)-7,8,9,12,13,14,20,25,26,27,30,31,32,35,36,37-Hexadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163192207)
- 8. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163191667)
- 9. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-46-[(2s,3r,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162818361)
- 10. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-46-[(2s,3s,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162818358)
- 11. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2r,3r,4r,5s)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162996101)
- 12. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3r,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163193937)
- 13. (1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2s,3s,4s,5r)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163194913)
- 14. (1r,2r,20r,42s,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-15-[(1r,2r,20r,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162924018)
- 15. (1r,2r,20s,42s,46s)-15-[(1r,2s,20s,42r,46s)-7,8,9,12,13,14,20,25,26,27,30,31,32,35,36,37-Hexadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-46-[(2r,3r,4r,5s)-2,3,4,5-Tetrahydroxyoxan-2-Yl]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162818371)
- 16. (1r,2r,20s,42s,46s)-15-[(1r,2s,20s,42s,46s)-7,8,9,12,13,14,20,25,26,27,30,31,32,35,36,37-Hexadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-46-Yl]-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11(16),12,14,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163192017)
- 17. (1r,2r,20s,42s,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-46-Carboxylic Acid (PubChem CID: 163029476)
- 18. (1r,2s,19r,41s,45r)-7,8,9,12,13,14,24,25,26,30,31,34,35,36,45-Pentadecahydroxy-29-Methyl-3,18,20,40,42-Pentaoxanonacyclo[26.13.3.137,41.02,19.05,10.011,16.022,27.032,44.033,38]pentatetraconta-5,7,9,11,13,15,22,24,26,28,30,32(44),33(38),34,36-Pentadecaene-4,17,21,39,43-Pentone (PubChem CID: 162962894)
- 19. (1s,2r,20r,42s,46r)-7,8,9,12,13,14,26,27,30,31,32,35,36,37,46-Pentadecahydroxy-25-[[(1s,2r,20s,42s,46r)-7,8,9,12,13,25,26,27,30,31,32,35,36,37,46-Pentadecahydroxy-4,17,22,40,44-Pentaoxo-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaen-14-Yl]oxy]-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163192218)
- 20. (1s,2r,20s,42s,46r)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 162934486)
- 21. (1s,2r,20s,42s,46s)-7,8,9,12,13,14,25,26,27,30,31,32,35,36,37,46-Hexadecahydroxy-3,18,21,41,43-Pentaoxanonacyclo[27.13.3.138,42.02,20.05,10.011,16.023,28.033,45.034,39]hexatetraconta-5,7,9,11,13,15,23,25,27,29(45),30,32,34(39),35,37-Pentadecaene-4,17,22,40,44-Pentone (PubChem CID: 163193900)
- 22. (1s,2s,19r,41r,45s)-7,8,9,12,13,14,24,25,26,30,31,34,35,36,45-Pentadecahydroxy-29-Methyl-3,18,20,40,42-Pentaoxanonacyclo[26.13.3.137,41.02,19.05,10.011,16.022,27.032,44.033,38]pentatetraconta-5,7,9,11,13,15,22,24,26,28,30,32(44),33(38),34,36-Pentadecaene-4,17,21,39,43-Pentone (PubChem CID: 162962893)
- 23. (1s,2s,3s,5s,8r,9s,10r,11s,12s)-3,12-Dihydroxy-11-Methyl-6-Methylidene-16-Oxo-15-Oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-Carboxylic Acid (PubChem CID: 21596345)
- 24. (1s,3ar,3bs,5ar,6r,8as,8bs)-3a,5a-Dimethyl-6-[(E,2r,5s)-5-Methylhept-3-En-2-Yl]-1,2,3,3b,4,5,6,7,8,8a,8b,9-Dodecahydroindeno[5,4-E]inden-1-Ol (PubChem CID: 163076709)
- 25. (2r)-2-[(2s,5r,9s)-2-[(S)-[(2r,5r)-5-[(1s,3r,5s)-1-[(2r,5r)-5-[(2r,3e,5e)-6-[(2r,3r,5s)-5-[(2r,3r,4r)-2-Hexadecanoyloxy-3-Hydroxy-4-Methyloxan-2-Yl]-3-Hydroxyoxolan-2-Yl]-2,4-Dimethylhexa-3,5-Dienyl]-5-Methyloxolan-2-Yl]-5-Methyl-2,8-Dioxabicyclo[3.2.1]octan-3-Yl]-2-Methyl-4-Oxooxolan-2-Yl]-Hydroxymethyl]-1,10-Dioxaspiro[4.5]decan-9-Yl]propanoic Acid (PubChem CID: 163101767)
- 26. (2r)-3-[(2s,6r,8r,11r)-2-[(E,2r)-4-[(2s,2'r,4r,4ar,6r,8as)-2-[(1s,3s)-1,3-Dihydroxy-3-[(2s,3r,6s)-3-Methyl-1,7-Dioxaspiro[5.5]undecan-2-Yl]propyl]-4-Hydroxy-3-Methylidenespiro[4a,7,8,8a-Tetrahydro-4h-Pyrano[3,2-B]pyran-6,5'-Oxolane]-2'-Yl]but-3-En-2-Yl]-11-Hydroxy-4-Methyl-1,7-Dioxaspiro[5.5]undec-4-En-8-Yl]-2-Hydroxy-2-Methylpropanoic Acid (PubChem CID: 163088763)
- 27. (2r,2'r,3s,3's,4s)-2,2'-Bis(3,4-Dihydroxyphenyl)-5,5',7,7'-Tetrahydroxy-[4,8'-Bichroman]-3,3'-Diyl Bis(3,4,5-Trihydroxybenzoate) (PubChem CID: 12795892)
- 28. (2s)-2-[[4-[(2-Amino-4-Oxo-1h-Pteridin-6-Yl)methylamino]benzoyl]amino]pentanedioic Acid (PubChem CID: 6037)
- 29. (2s,3s,4s)-4-[(2e,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916711)
- 30. (2s,3s,4s)-4-[(2z,4z,6s)-6-Carboxyhepta-2,4-Dien-2-Yl]-3-(Carboxymethyl)pyrrolidine-2-Carboxylic Acid (PubChem CID: 162916712)
- 31. (2z,4e,6e,8e,10e,12e,14e,16e)-3-Hydroxy-19-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-1-[(1r,4s)-4-Hydroxy-1,2,2-Trimethylcyclopentyl]-4,8,13,17-Tetramethylnonadeca-2,4,6,8,10,12,14,16-Octaen-18-Yn-1-One (PubChem CID: 162912290)
- 32. (3r,3'r)-3'-(3-Hydroxyphenyl)-4-Methylspiro[1h-1,4-Benzodiazepine-3,2'-Oxirane]-2,5-Dione (PubChem CID: 92278353)
- 33. (3r,5s)-5-[(1r,4s,6r,7s,9r,10e,12r,17r,19r,20s,29s,32s)-9,32-Dihydroxy-6,10,13,19,20,32-Hexamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 162927161)
- 34. (3r,5s)-5-[(1s,4s,6s,7r,9r,10e,12s,17r,20r,29s,32s)-9,32-Dihydroxy-6,10,13,20,32-Pentamethyl-27-Methylidene-33,34,35-Trioxa-22-Azahexacyclo[27.3.1.11,4.14,7.012,17.017,23]pentatriaconta-10,13,22-Trien-14-Yl]-3-Methyloxolan-2-One (PubChem CID: 163190285)
- 35. (3s,4as,6as,6as,6br,8ar,12ar,14ar,14br)-4,4,4a,6a,6b,8a,11,11,14a-Nonamethyl-2,3,5,6,6a,7,8,9,10,12,12a,13,14,14b-Tetradecahydro-1h-Picen-3-Ol (PubChem CID: 162962747)
- 36. (3s,5r,8r,9r,10r,13s,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 12309018)
- 37. (3s,5s,8r,9r,10r,13r,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-Dodecahydro-1h-Cyclopenta[A]phenanthren-3-Ol (PubChem CID: 162965657)
- 38. (3s,8as)-3-[[(3r)-7,7-Dimethyl-3-(2-Methylbut-3-En-2-Yl)-2-Oxo-1h-Pyrano[2,3-G]indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 16127840)
- 39. (3s,8as)-3-[[2-(2,2-Dimethylbut-3-Enyl)-1h-Indol-3-Yl]methyl]-2,3,6,7,8,8a-Hexahydropyrrolo[1,2-A]pyrazine-1,4-Dione (PubChem CID: 163091236)
- 40. (4as,6as,6as,6br,8ar,12as,14as,14br)-4,4,6a,6b,8a,11,11,14a-Octamethyl-2,4a,5,6,6a,7,8,9,10,12,12a,13,14,14b-Tetradecahydro-1h-Picen-3-One (PubChem CID: 162992395)
- 41. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 23428074)
- 42. (4r,5r)-4-Hydroxy-4-[(3e,5e,7e,9e,11e,13e,15e)-18-[(4s)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-3,7,12,16-Tetramethyl-2-Oxooctadeca-3,5,7,9,11,13,15-Heptaen-17-Ynyl]-3,3,5-Trimethylcyclohexan-1-One (PubChem CID: 162865461)
- 43. (5r,8r,9s,10r,13r,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 12309262)
- 44. (5s,8r,9r,10r,13r,14r,17s)-17-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-4,4,8,10,14-Pentamethyl-1,2,5,6,7,9,11,12,13,15,16,17-Dodecahydrocyclopenta[A]phenanthren-3-One (PubChem CID: 124303726)
- 45. (5z)-5-((2e,4e,6e,8e)-11-((4r)-4-Hydroxy-2,6,6-Trimethyl-1-Cyclohexen-1-Yl)-2,9-Dimethyl-2,4,6,8-Undecatetraen-10-Yn-1-Ylidene)-3-((1e)-2-((1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo(4.1.0)hept-1-Yl)ethenyl)-2(5h)-Furanone (PubChem CID: 134741793)
- 46. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1r,2r,4s)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162883665)
- 47. (5z)-5-[(2e,4e,6e)-9-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-7-Methylnona-2,4,6-Trien-8-Ynylidene]-3-[(E)-2-[(1s,4s,6r)-4-Hydroxy-2,2,6-Trimethyl-7-Oxabicyclo[4.1.0]heptan-1-Yl]ethenyl]furan-2-One (PubChem CID: 162880763)
- 48. (5z)-5-[(2e,4e,6e,8e)-11-[(4r)-4-Hydroxy-2,6,6-Trimethylcyclohexen-1-Yl]-2,9-Dimethylundeca-2,4,6,8-Tetraen-10-Ynylidene]-3-[(E)-2-[(1s,2s,4r)-1,2,4-Trihydroxy-2,6,6-Trimethylcyclohexyl]ethenyl]furan-2-One (PubChem CID: 162896470)
- 49. (E)-Tetradec-5-En-1-Ol (PubChem CID: 6431325)
- 50. 1-Acetyl-24-Epi-Polacandrin (PubChem CID: 11752980)
- 51. 1-Epi-Castalagin (PubChem CID: 12302512)
- 52. 1-Methoxy-9,10-Anthracenedione (PubChem CID: 6707)
- 53. 11,11-Dihydroxysaxitoxin (PubChem CID: 102411284)
- 54. 11beta-Hydroxy-N21-Sulfocarbamoylsaxitoxin (PubChem CID: 136045808)
- 55. 19'-Hexanoyloxyisomytiloxanthin (PubChem CID: 16061209)
- 56. 2-Hydroxychrysophanol (PubChem CID: 442759)
- 57. 3'',4''-Di-O-Acetyl-2'',6''-Di-O-P-Coumaroylastragalin (PubChem CID: 10328097)
- 58. 3,3'-Methylenebis(Tyrosine) (PubChem CID: 3082144)
- 59. 3,4,5-Trimethoxybenzoic Acid (PubChem CID: 8357)
- 60. 3-[(3s,3ar,5ar,6s,7r,9ar,9br)-3-[(2s)-2-Hydroxy-6-Methylhept-5-En-2-Yl]-6,9a,9b-Trimethyl-7-Prop-1-En-2-Yl-1,2,3,3a,4,5,5a,7,8,9-Decahydrocyclopenta[A]naphthalen-6-Yl]propanoic Acid (PubChem CID: 162903148)
- 61. 3-Hydroxy-1-(4-Hydroxy-3,5-Dimethoxyphenyl)-1-Propanone (PubChem CID: 75142)
- 62. 6-Tetradecen-1-Ol, (E) (PubChem CID: 6431327)
- 63. 6beta-Hydroxystigmast-4-En-3-One (PubChem CID: 9823926)
- 64. 7-Dehydrocholesterol (PubChem CID: 439423)
- 65. 9,10-Dioxoanthracene-2-Carboxylic Acid (PubChem CID: 67030)
- 66. [(2r,3r,4r)-4-[(2r,3s)-2-(3,4-Dihydroxyphenyl)-3,5,7-Trihydroxy-3,4-Dihydro-2h-Chromen-8-Yl]-5,7-Dihydroxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 13831071)
- 67. [(2r,3r,4s,5r,6s)-4,5-Diacetyloxy-6-[5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxochromen-3-Yl]oxy-3-[(Z)-3-(4-Hydroxyphenyl)prop-2-Enoyl]oxyoxan-2-Yl]methyl (E)-3-(4-Hydroxyphenyl)prop-2-Enoate (PubChem CID: 10418008)
- 68. [(2r,3s)-2-(3,4-Dihydroxyphenyl)-8-[(2r,3r,4s)-8-[(2r,3r,4r)-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3,4-Dihydro-2h-Chromen-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 163040999)
- 69. [(2r,3s)-2-(3,4-Dihydroxyphenyl)-8-[(2r,3r,4s)-8-[(2r,3r,4r)-2-(3,4-Dihydroxyphenyl)-8-[(2r,3r,4r)-8-[(2r,3s,4s)-2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-3,4-Dihydro-2h-Chromen-4-Yl]-3,5,7-Trihydroxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-4-Yl]-3,5,7-Trihydroxy-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3-(3,4,5-Trihydroxybenzoyl)oxy-2-(3,4,5-Trihydroxyphenyl)-3,4-Dihydro-2h-Chromen-4-Yl]-5,7-Dihydroxy-3,4-Dihydro-2h-Chromen-3-Yl] 3,4,5-Trihydroxybenzoate (PubChem CID: 162888081)
- 70. [(2s,3r,4s,5r,6s)-6-[5,7-Dihydroxy-2-(4-Hydroxyphenyl)-4-Oxochromen-3-Yl]oxy-3,4,5-Trihydroxyoxan-2-Yl]methyl (4r)-4-(2-Hydroxypropan-2-Yl)cyclohexene-1-Carboxylate (PubChem CID: 162849269)
- 71. [(3r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-4,4a,6a,6b,8a,11,11,14a-Octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-Hexadecahydropicen-3-Yl] Acetate (PubChem CID: 13688749)
- 72. Alloxanthin (PubChem CID: 6443740)
- 73. Alpha-Tocopherol (PubChem CID: 14985)
- 74. Amarouciaxanthin B/sidnyaxanthin (PubChem CID: 16061221)
- 75. Anandamide (PubChem CID: 5281969)
- 76. Aspermytin A (PubChem CID: 9993091)
- 77. Azaspiracid-3 (PubChem CID: 131842452)
- 78. Beta-Carotene (PubChem CID: 5280489)
- 79. Beta-Ionone (PubChem CID: 638014)
- 80. Beta-Sitosterol (PubChem CID: 222284)
- 81. Betaine (PubChem CID: 247)
- 82. Butin (PubChem CID: 92775)
- 83. Capric Acid (PubChem CID: 2969)
- 84. Carnosol (PubChem CID: 442009)
- 85. Caryophyllene (PubChem CID: 5281515)
- 86. Cianidanol (PubChem CID: 9064)
- 87. Cid 101396440 (PubChem CID: 101396440)
- 88. Cid 12302513 (PubChem CID: 12302513)
- 89. Cid 154735200 (PubChem CID: 154735200)
- 90. Cid 15816477 (PubChem CID: 15816477)
- 91. Cid 162860366 (PubChem CID: 162860366)
- 92. Cid 162883225 (PubChem CID: 162883225)
- 93. Cid 162887352 (PubChem CID: 162887352)
- 94. Cid 162913940 (PubChem CID: 162913940)
- 95. Cid 162985394 (PubChem CID: 162985394)
- 96. Cid 162999788 (PubChem CID: 162999788)
- 97. Cid 163014543 (PubChem CID: 163014543)
- 98. Cid 163032184 (PubChem CID: 163032184)
- 99. Cid 163076592 (PubChem CID: 163076592)
- 100. Cid 17753955 (PubChem CID: 17753955)
- 101. Cid 23428237 (PubChem CID: 23428237)
- 102. Cyanidin 3-(6''-Acetyl-Galactoside) (PubChem CID: 122396785)
- 103. Cyanidin 3-(6''-Succinyl-Glucoside) (PubChem CID: 100917934)
- 104. Deoxynupharidine (PubChem CID: 442525)
- 105. Di-O-Methylcrenatin (PubChem CID: 10736338)
- 106. Dihydrodehydrodiconiferyl Alcohol (PubChem CID: 384679)
- 107. Domoic Acid C5'-Diastereomer (PubChem CID: 5311075)
- 108. Epicatechin (PubChem CID: 72276)
- 109. Epicatechin 3-O-Gallate(4b->8)epigallocatechin-3-O-Gallate (PubChem CID: 11622083)
- 110. Epicatechin Gallate (PubChem CID: 107905)
- 111. Epicatechin-(4beta->8)-Epigallocatechin 3'-Gallate (PubChem CID: 11513300)
- 112. Epigallo Catechin Gallate (PubChem CID: 5276454)
- 113. Epigallocatechin (PubChem CID: 72277)
- 114. Epigallocatechin Gallate (PubChem CID: 65064)
- 115. Ergosterol (PubChem CID: 444679)
- 116. Etoposide (PubChem CID: 36462)
- 117. Fisetin (PubChem CID: 5281614)
- 118. Fisetinidol-4alpha-Ol (PubChem CID: 164762)
- 119. Friedelin (PubChem CID: 91472)
- 120. Furopelargone A (PubChem CID: 6451194)
- 121. Gallocatechin (PubChem CID: 65084)
- 122. Gamma-Tocopherol (PubChem CID: 92729)
- 123. Gentisic Acid (PubChem CID: 3469)
- 124. Gentisin (PubChem CID: 5281636)
- 125. Glutinol (PubChem CID: 9932254)
- 126. Glutinone (PubChem CID: 10071029)
- 127. Halocynthiaxanthin (PubChem CID: 11966451)
- 128. Heptacosane (PubChem CID: 11636)
- 129. Hexadecanoic Acid Propylamide (PubChem CID: 10379895)
- 130. Hexose (PubChem CID: 206)
- 131. Himeic Acid A (PubChem CID: 11774903)
- 132. Himeic Acid B (PubChem CID: 21579676)
- 133. Himeic Acid C (PubChem CID: 21777983)
- 134. Isodomoic Acid F (PubChem CID: 101790920)
- 135. Kaempferol-3-O-(2',6'-Di-O-Trans-P-Coumaroyl)-Beta-D-Glucopyranoside (PubChem CID: 10439991)
- 136. Ligucyperonol (PubChem CID: 14681770)
- 137. Linoleic Acid (PubChem CID: 5280450)
- 138. Linolenic Acid (PubChem CID: 5280934)
- 139. Methyl (Z,e)-4-(Geranyloxy)cinnamate (PubChem CID: 71720677)
- 140. Methyl Cis-P-Coumarate 3-(3,7-Dimethyl-2,6-Octadienyl) (PubChem CID: 51349869)
- 141. Mytiloxanthin (PubChem CID: 11365423)
- 142. N,n,n-Trimethylglycinium (PubChem CID: 248)
- 143. Nicotinic Acid (PubChem CID: 938)
- 144. Notoamide A (PubChem CID: 16128040)
- 145. Notoamide B (PubChem CID: 16127923)
- 146. Notoamide D (PubChem CID: 16127841)
- 147. Notoamide F (PubChem CID: 25180710)
- 148. Notoamide G (PubChem CID: 25180707)
- 149. Notoamide H (PubChem CID: 25180895)
- 150. Notoamide I (PubChem CID: 25180708)
- 151. Notoamide J (PubChem CID: 25180709)
- 152. Notoamide K (PubChem CID: 25180896)
- 153. Notoamide O (PubChem CID: 102043608)
- 154. Notoamide P (PubChem CID: 46919486)
- 155. Notoamide Q (PubChem CID: 46919487)
- 156. Notoamide R (PubChem CID: 46919488)
- 157. Nv766twa77 (PubChem CID: 102146782)
- 158. P-Anisaldehyde (PubChem CID: 31244)
- 159. P-Coumaric Acid (PubChem CID: 637542)
- 160. Pectenol A/(Pectenol) (PubChem CID: 16061215)
- 161. Phytic Acid (PubChem CID: 890)
- 162. Pratensein (PubChem CID: 5281803)
- 163. Procyanidin B3 (PubChem CID: 146798)
- 164. Prodelphinidin B3 (PubChem CID: 13831068)
- 165. Pyridoxine (PubChem CID: 1054)
- 166. Quercitol (PubChem CID: 441437)
- 167. Riboflavin (PubChem CID: 493570)
- 168. Sclerotiamide (PubChem CID: 10647785)
- 169. Scopoletin (PubChem CID: 5280460)
- 170. Stigmasterol (PubChem CID: 5280794)
- 171. Swertiamarin (PubChem CID: 442435)
- 172. Taraxerol (PubChem CID: 92097)
- 173. Thiamine (PubChem CID: 1130)
- 174. Thiobinupharidine (PubChem CID: 442554)
- 175. Trachelosperogenin A1, >=95% (Lc/ms-Elsd) (PubChem CID: 21637743)
- 176. Veratraldehyde (PubChem CID: 8419)
- 177. Verbascoside (PubChem CID: 5281800)
- 1. Adenocarcinoma
- 2. Alzheimer's Disease 1
- 3. Anemia
- 4. Arthritis, Rheumatoid
- 5. Asthma
- 6. Cardiovascular Diseases
- 7. Carotid Stenosis
- 8. Cataract
- 9. Celiac Disease
- 10. Chancre
- 11. Cholera
- 12. Common Wart
- 13. Coronary Artery Disease
- 14. Crohn Disease
- 15. Cystic Fibrosis
- 16. Dental Caries
- 17. Diabetes Mellitus
- 18. Diabetes Mellitus, Type 1
- 19. Epilepsy
- 20. Glaucoma
- 21. Gonorrhea
- 22. Hematologic Diseases
- 23. Infertility, Male
- 24. Inflammatory Bowel Diseases
- 25. Leukemia, Lymphoid
- 26. Liver Neoplasms
- 27. Lupus Erythematosus, Systemic
- 28. Lymphoma
- 29. Malaria
- 30. Muscular Dystrophies
- 31. Myocardial Infarction
- 32. Obesity
- 33. Osteoarthritis
- 34. Osteoporosis
- 35. Pre-Eclampsia
- 36. Psoriasis
- 37. Stomatitis
- 38. Thrombocytopenia
- 39. Urinary Bladder Neoplasms
- 40. Urinary Tract Infections
- 41. Uterine Cervical Neoplasms
Not listed in any formulations.